Herpes Virus C5252 Injection: Clinical Trials

1 trial of Herpes Virus C5252 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Herpes Virus C5252 Injection: new trials by email Literature Review of Herpes Virus C5252 Injection trials Research Report on Herpes Virus C5252 Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor
Herpes Virus C5252 Injection - Glioma, Malignant
Phase 1 / Phase 2RecruitingImmVira Pharma Co. Ltd362026-04-032026-08-17

Conditions studied

Glioma (1)

Sponsors

ImmVira Pharma Co. Ltd (1)

Countries

China (1)